tiprankstipranks
Trending News
More News >
Aquestive Therapeutics, Inc. (AQST)
NASDAQ:AQST
US Market

Aquestive Therapeutics (AQST) Revenue

Compare
2,461 Followers

Aquestive Therapeutics Revenue

Aquestive Therapeutics had a revenue of 13.02M in the quarter ending Dec 31, 2025, with 1.62%. This bring the company's revenue in the last twelve months to 44.55M, Decreased 2.65%. In the fiscal year ending Dec 31, 2025, Aquestive Therapeutics had annual revenue of 44.55M with -22.61% growth.
Revenue (ttm)
44.55M
Revenue Growth
-26.32%
P/S Ratio
10.90
Revenue/Employee
$313,697
Employees
142
Market Cap
$485.74M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
44.55M-13.02M-22.61%
Dec 31, 2024
57.56M6.98M+13.80%
Dec 31, 2023
50.58M2.90M+6.09%
Dec 31, 2022
47.68M-3.15M-6.20%
Dec 31, 2021
50.83M4.98M+10.87%
Dec 31, 2020
45.85M-6.76M-12.85%
Dec 31, 2019
52.61M-14.82M-21.98%
Dec 31, 2018
67.43M512.00K+0.77%
Dec 31, 2017
66.92M